Review
[Central serous chorioretinopathy--uptodate treatment options]
[Article in
Russian]
- PMID: 23367766
Item in Clipboard
Review
[Central serous chorioretinopathy--uptodate treatment options]
[Article in
Russian]
Vestn Oftalmol.
2012 Nov-Dec.
Abstract
The review of literature is devoted to the uptodate treatment options of central serous chorioretinopathy.
Similar articles
-
Intravitreal bevacizumab versus the conventional protocol of photodynamic therapy for treatment of chronic central serous chorioretinopathy.Acta Ophthalmol. 2011 May;89(3):e293-4. doi: 10.1111/j.1755-3768.2009.01835.x. Acta Ophthalmol. 2011. PMID: 20346078 No abstract available.
-
Central Serous Chorioretinopathy Treatments: A Mini Review.Ophthalmic Res. 2015;55(2):76-83. doi: 10.1159/000441502. Epub 2015 Dec 1. Ophthalmic Res. 2015. PMID: 26619293 Review.
-
Central serous chorioretinopathy: what we have learnt so far.Acta Ophthalmol. 2016 Jun;94(4):321-5. doi: 10.1111/aos.12779. Epub 2015 Jul 1. Acta Ophthalmol. 2016. PMID: 26132864 Review.
-
Intravitreal bevacizumab injection for central serous chorioretinopathy.Retina. 2010 Sep;30(8):1322-3; author reply 1323. doi: 10.1097/IAE.0b013e3181e445b4. Retina. 2010. PMID: 20827148 No abstract available.
-
Intravitreal bevacizumab injection for central serous chorioretinopathy.Retina. 2010 Sep;30(8):1323-24; author reply 1324. doi: 10.1097/IAE.0b013e3181e46b09. Retina. 2010. PMID: 20661171 No abstract available.